Click here for the online version of the Newsletter.


[Dear Sir or Madam,

With this newsletter we would like to inform you about current regulatory affairs developments and trends with regard to Good Manufacturing Practices (GMP).

Your
ECA Team

1. FDA´s new policy regarding grouping of supplements for CMC changes

The US Food and Drug Administration’s (FDA) Office of Pharmaceutical Quality (OPQ) released a new document outlining how supplements can be grouped together and submitted concurrently for the same chemistry, manufacturing and controls (CMC) changes. Find out more about Policy and Procedures regarding the Review of Grouped Product Quality Supplements.

↑ top

2. Handling Changes and Variations
 

This course from 18-19 October 2016  in Vienna is intended to provide you with guidance on how to efficiently submit and process variations in the EU. Furthermore, you will learn how to manage changes in a multi customer situation using ASMFs or CEPs. Please see the programme for further information.

↑ top

3. FDA releases new internal policy on ICH Q8, Q9, Q10 Guidelines

On May 18, 2016, the US Food and Drug Administration (FDA) released a new policy document on applying ICH Q8, Q9, and Q10 principles to chemistry, manufacturing, and controls review. Read more on how agency staff in the Office of Pharmaceutical Quality (OPQ) should apply the recommendations in the ICH Q8, Q9 and Q 10 guidelines to CMC reviews.

↑ top

4. Lifecycle Approach of Analytical Procedures
USP and ECA Joint Conference and Workshop

 

The United States Pharmacopeial Convention (USP) and the ECA Academy announce their cooperation in organising a joint conference entitled, “Lifecycle Approach to Analytical Procedures”. The conference will take place in Prague, Czech Republic, on 8th and 9th November 2016 at the Corinthia Hotel. Conference presentations, case studies and open discussions will help you to learn more about the lifecycle management of analytical procedures.Take further advantage if this forum to discuss USP’s new general chapter and Stimuli articles related to this topic. You will thus have the opportunity to give feedback and ask questions directly to USP’s Expert Panel Members on how to move forward with the transition to and implementation of the lifecycle approach. Please see the conference website for further information.

↑ top

5. In case you missed the previous GMP Newsletter, here are the news from the last
    GMP Newsletter:

For further recent news please go here.

↑ top

6. Forthcoming GMP/FDA Events

Here you will find an updated overview of forthcoming education courses and conferences.

↑ top

GMP Search

Are you looking for GMP information on the web? Try www.gmp-search.com and search in the databases of ECA, FDA, EMA, ICH, PIC/S.

  • DO NOT REPLY TO THIS E-MAIL! If you have any questions, please write to support@gmp-compliance.org.
  • You are subscribed to the GMP Newsletter with the e-mail address [email]. If you do not want to receive further e-mails from us, please click here.
  • Past issues of the GMP News can be found under "News/GMP News Archive" at http://www.gmp-compliance.org/

Yours sincerely,

The European Compliance Academy

We have entrusted the following service provider to send this message to you:
Concept Heidelberg GmbH, Rischerstraße 8, 69123 Heidelberg, Germany
Managing Director: Oliver Schmidt - Registration: HRB Mannheim No. 705125
The information contained in this e-mail is the copyright of Concept Heidelberg GmbH. The content (or parts of it) may only be used with the express permission of Concept Heidelberg GmbH.
The contents of the GMP Newsletter have been compiled with great care. However, we cannot guarantee the completeness, accuracy and topicality of the contents.

↑ top